🇺🇸 FDA
Patent

US 10028949

Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same

granted A61KA61K31/255A61K31/496

Quick answer

US patent 10028949 (Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same) held by Platform Brightworks Two, Ltd. expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Platform Brightworks Two, Ltd.
Grant date
Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/255, A61K31/496, A61K47/02, A61K47/10